Issue Date | Title | Author(s) |
2016-04-01 | Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells | Rahman, MM; Rumzhum, NN; Hansbro, PM; Morris, JC; Clark, AR; Verrills, NM; Ammit, AJ |
2015-05-18 | Basal protein phosphatase 2A activity restrains cytokine expression: Role for MAPKs and tristetraprolin | Rahman, MM; Rumzhum, NN; Morris, JC; Clark, AR; Verrills, NM; Ammit, AJ |
2023-03-28 | Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies. | Germon, ZP; Sillar, JR; Mannan, A; Duchatel, RJ; Staudt, D; Murray, HC; Findlay, IJ; Jackson, ER; McEwen, HP; Douglas, AM; McLachlan, T; Schjenken, JE; Skerrett-Byrne, DA; Huang, H; Melo-Braga, MN; Plank, MW; Alvaro, F; Chamberlain, J; De Iuliis, G; Aitken, RJ; Nixon, B; Wei, AH; Enjeti, AK; Huang, Y; Lock, RB; Larsen, MR; Lee, H; Vaghjiani, V; Cain, JE; de Bock, CE; Verrills, NM; Dun, MD |
2019-01-01 | Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease | Nair, PM; Starkey, MR; Haw, TJ; Liu, G; Collison, AM; Mattes, J; Wark, PA; Morris, JC; Verrills, NM; Clark, AR; Ammit, AJ; Hansbro, PM |
2016-11-16 | The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells | Rahman, MM; Prünte, L; Lebender, LF; Patel, BS; Gelissen, I; Hansbro, PM; Morris, JC; Clark, AR; Verrills, NM; Ammit, AJ |
2012-02-01 | PP2A phosphatase suppresses function of the mesenchymal invasion regulator NEDD9 | Bradbury, P; Mahmassani, M; Zhong, J; Turner, K; Paul, A; Verrills, NM; O'Neill, GM |
2019-10-17 | Protein phosphatase 2A (PP2A): A key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer | Nader, CP; Cidem, A; Verrills, NM; Ammit, AJ |
2022 | Role of the prorenin receptor in endometrial cancer cell growth. | Martin, JH; Mohammed, R; Delforce, SJ; Skerrett-Byrne, DA; de Meaultsart, CC; Almazi, JG; Stephens, AN; Verrills, NM; Dimitriadis, E; Wang, Y; Lumbers, ER; Pringle, KG |
2020-12 | Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia. | Dun, MD; Mannan, A; Rigby, CJ; Butler, S; Toop, HD; Beck, D; Connerty, P; Sillar, J; Kahl, RGS; Duchatel, RJ; Germon, Z; Faulkner, S; Chi, M; Skerrett-Byrne, D; Murray, HC; Flanagan, H; Almazi, JG; Hondermarck, H; Nixon, B; De Iuliis, G; Chamberlain, J; Alvaro, F; de Bock, CE; Morris, JC; Enjeti, AK; Verrills, NM |
2017-12-01 | Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice | Nair, PM; Starkey, MR; Haw, TJ; Liu, G; Horvat, JC; Morris, JC; Verrills, NM; Clark, AR; Ammit, AJ; Hansbro, PM |
2016-06-01 | Theophylline represses IL-8 secretion from airway smooth muscle cells independently of phosphodiesterase inhibition: Novel role as a protein phosphatase 2A activator | Patel, BS; Rahman, MM; Rumzhum, NN; Oliver, BG; Verrills, NM; Ammit, AJ |
2016-09-01 | TLR2 ligation induces corticosteroid insensitivity in A549 lung epithelial cells: Anti-inflammatory impact of PP2A activators | Rahman, MM; Prabhala, P; Rumzhum, NN; Patel, BS; Wickop, T; Hansbro, PM; Verrills, NM; Ammit, AJ |